EXPERIMENTAL STUDIES OF BEHAVIORAL EFFECTS OF MEPROBAMATE ON NORMAL SUBJECTS by Marquis, Donald G. et al.
EXPERIMENTAL STUDIES OF BEHAVIORAL EFFECTS OF 
MEPROBAMATE ON NORMAL SUBJECTS 
By Donald G. Marquis, E. Lowell Kelly, James G. Miller, 
Ralph W. Gerard, and Anatol Rapoport 
University of Michigan, Ann Arbor, Miclz. 
With the increasing use of meprobamate, it is important to know its effects on 
the behavior of relatively normal subjects, on persons who take the drug without 
discontinuing their usual activities. We need detailed information about the 
effects of the drug on those common but complex acts in which most people 
engage as part of their daily lives. One of these activities-potentially dan- 
gerous if not properly carried out-is driving an automobile. How does 
meprobamate affect the motor skills, the sensory processes, and the judgment 
necessary for safe driving? Does meprobamate in usual doses, alone or in 
combination with a martini or a drink of whiskey, make it likely that a driver 
will endanger his own life or the lives of others? The answers to these and 
related questions have become increasingly important in view of the rapid 
changes occurring in our modern world. 
Although some information on these issues can be obtained from general ob- 
servation and from subjective reports, our knowledge about the drug’s effects 
will be much sounder if the data are obtained under standardized and controlled 
conditions. Our research, including studies of reaction time, driving skills, 
steadiness, and visual performance, was designed to accomplish this. 
Drug Administration 
Fifty adult subjects were tested on 5 successive days, on each of which they 
received one of the following doses: (1) a placebo (lactose, 1400 mg.); (2) 
meprobamate (800 mg.); (3) dextroamphetamine sulfate (15 mg.) ; (4) mepro- 
bamate (800 mg.) plus alcohol (2 oz. of 86-proof whiskey); and ( 5 )  a placebo 
(lactose, 1400 mg.) plus alcohol (2 02. of 86-proof whiskey). The placebo, 
meprobamate, and dextroamphetamine sulfate were in capsules and were not 
identified to the subjects. There were 2 capsules of meprobamate in each 
treatment, 2 capsules for the placebo, and 1 for the dextroamphetamine sul- 
fate. Since the 
experimenters were, therefore, necessarily aware of some of the treatmentsgiven, 
the research design was not a “double blind,” the procedure a t  present so highly 
regarded for evaluating drugs. Because we were using objective behavioral 
measures, however, the blind method did not seem so essential as when effects 
of drugs on patients are to be rated or evaluated clinically. I t  seems unlikely 
that the information unavoidably revealed to the experimenters could have 
affected the scores on any of our procedures. Perhaps an ultimate objective 
quantification of such measures of change may eliminate the need for elaborate 
double-blind controls. 
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Testimg Procedures 
All the subjects were tested in small rooms in the Ann Arbor Veterans Ad- 
ministration Hospital. Testing was done on consecutive working days, omit- 
ting week ends, and each subject was tested at approximately the same hour 
each day. On the first day of testing the experimenter explained to the sub- 
ject that the purpose of the experiment was to learn the effects of certain drugs 
on driving, and that the drugs administered would have no serious effects. It 
is likely that most of the paid subjects knew through “the grapevine” that 
meprobamate and alcohol were two of the drugs to be used, but they were not 
so informed by the experimenters. I n  order to permit the most efficient use of 
time, subjects were seen in pairs. While one was operating the auto trainer in 
one room with one experimenter, the other was being given the remaining tests 
in another room by a second experimenter. 
Upon entering the waiting room the subjects were given one of the drugs or 
placebos; a 30-minute waiting period was allowed for it to take effect. The 
order of presentation of the drugs over the 5-day period varied from subject to 
subject in such a way that each treatment occurred equally often a t  each stage 
of practice, and each treatment followed every other treatment with equal fre- 
quency. Each day the subject received a different treatment, so that a t  the 
end of the 5-day testing period he had received them all. During the waiting 
period on the first day the subjects were interviewed for background and 
personal information and were given a 15-minute practice session on the 
driving task. Half received the interview first, and half received the driving 
practice first. 
The tasks were then switched. 
Subjects 
Of the 50 subjects, 36 were men and 14 were women. The range in age was 
from 21 to 50, 30 of the subjects being between 21 and 29. Twenty-nine were 
college students, 9 were patients with medical (not neuropsychiatric) illnesses 
in a Veterans Administration hospital, 5 were patients in a neurosis center, 
and 7 were Veterans Administration employees. Most of these persons were 
normal, in the sense that they did not suffer from obvious personality difficulties 
or mental illnesses, and none was psychotic. Thirty-seven replied “no” to 
the question, “Have you or has any member of your family been bothered by 
fits, faints, or nervousness?” Of the remainder, 8 gave a personal history, 3 a 
family history, and 2 both a personal and a family history of such symptoms. 
I t  appeared to us that this probably was a reasonably representative sample 
in terms of the mental status of the types of persons a t  present receiving mepro- 
bamate. 
Of those subjects who were hospital patients, 9 had been hospitalized less 
than 1 month, 1 for 1 month, 1 for 2 months, 2 for from 3 to 5 months, and 1 
for between 6 months and a year. 
All subjects were volunteers. The student subjects were paid, while the 
others were not. 
Because of the relationships of body weight to drug effects, the subjects’ 
weights were taken. Eleven weighed between 90 and 124 lb., 11 between 125 
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and 139,4 between 140 and 154,9 between 155 and 169, and 9 between 170 and 
184. The remaining 6 weighed more than 185 lb. 
Thirty-four of the subjects were accustomed to driving daily, 7 drove a t  least 
weekly, and only 9 drove seldom or not a t  all. 
Forty of the subjects reported that they had never taken tranquilizing drugs; 
the other 10 had taken them only infrequently. Thirteen said they were 
moderate drinkers, 31 reported they were light drinkers, and 6 said they did not 
drink alcohol a t  all. None admitted being a heavy drinker or having a history 
of alcoholism. 
Apparatus and Results 
For the driving tests, the American Automobile Association’s “Auto Trainer” 
was used (FIGURE 1). This apparatus consists of 2 parts: the first includes all 
the controls of a conventional-shift automobile--starter button, speedometer, 
steering wheel, gear-shift lever, ignition key, and accelerator, brake, and clutch 
pedals; the second part is a treadmill-like belt about 10 feet long, which extends 
from the front of the control unit. The belt, painted to resemble a tortuous 
roadway, revolves when the controls are in gear, the speed being controlled 
by the accelerator. Tn our experiment, however, the apparatus was modified 
so that the speed could be set by the experimenter’s controls at  a constant fast 
FIGURE 1. American Automobile Association’s Auto Trainer, used for the driving test. 
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rate (equivalent to approximately 20 mph) or a slow rate (approximately 10 
mph). 
A small model car, the steering mechanism of which is controlled by the steer- 
ing wheel of the control unit, rests on the belt, its wheels turning as the belt 
revolves, and the speed of the belt determines its apparent speed. The task of 
the subject is to steer the car so that it remains in the center of the roadway 
painted on the belt. A red and a green light are situated a t  the far end of the 
belt unit. When the green light is on, the driver is to proceed; when the red 
light appears, he is to stop the car as rapidly as possible by depressing the 
brake. 
An accuracy counter, a reaction timer, a trial timer, and speed controls face 
the experimenter a t  the side of the control unit, out of sight of the subject. 
A foot switch with which the experimenter can turn on the red light is also 
connected to the side of the unit. Large staples are embedded in the “roadway” 
every 3 inches. If the car is kept in the center of the roadway, it makes contact 
with the staples, completing an electrical circuit and advancing the accuracy 
counter 1 unit. The reaction timer measures in hundredths of a second the 
time elapsed between the appearance of the red light and the brake-pressing 
response. 
The subjects were given trials as follows: 20 revolutions of the belt a t  a fixed 
slow speed; 20 a t  a fixed fast speed; and 20 a t  a speed controlled by the subject. 
Six reaction-time determinations were interspersed irregularly through each of 
the 3 trials. 
On the driving test, scores were obtained for accuracy a t  the fixed low speed, 
a t  the fixed high speed, and a t  the variable speed controlled by the subject. 
The unit of measurement was the number of staples over which the car passed. 
It will be remembered that the staples were embedded in the center of the road- 
way so that the subject had to keep the car in the middle of the road to activate 
the accuracy counter. In addition, a time score was obtained, indicating the 
time required for each trial when the subject was controlling his own speed. 
During this phase of the test the subject was asked to drive as rapidly and ac- 
curately as he could. A derived score was also figured-the ratio of the dif- 
ference between the accuracy score at  low fixed speed and the accuracy score a t  
subject-controlled speed, divided by the time score. This speed-accuracy 
ratio, which indicated the degree to which speed was sacrificed for accuracy, or 
vice versa, may be interpreted as a measure of judgment. Scores on the 
driving-test measures and on all other tests under the various drug conditions, 
as compared with the placebo condition, are presented in TABLE 1. 
Reaction times for the brake-pressing response were taken while the car 
was being driven a t  low fixed speed, at  fast fixed speed, and a t  variable speed. 
As can be seen in TABLE 1, none of the drug treatments produced a significant 
change on the speed of reaction, nor on any of the other driving-test scores*. 
* The lack of significant difference in braking time under meprobamate and under placebo 
is consistent with our earlier study of visual reaction time in 20 subjects under laboratory 
conditions. The reaction times of each subject were measured in a session twice daily for 3 
successive days. Each session consisted of 10 separate reaction-time measurements aiter 3 
practices. No drug was given the first and third days, but the trials on the second day were 
conducted 6 and 12 hours after the subjects had taken 800 mg. of meprobamate. The findings 
indicated that meprobamate does not lengthen visual reaction time so measured. 
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TABLE I 
MEAN DIEFERENCES BETWEEN SCORES UNDER EACH OF FOUR DRUG CONDITIONS 
UNDER PLACEBO 
Differences between scores in standard deviation 





Fixed low speed. . . . . . . . . . . .  
Fixed high speed, . . . . . . . . . . .  
Variable speed.. , . . , . . , . , . . , 
Variable speed.. . . . . . . . . . . . .  
Fixed low speed. . . . . . . . . . . .  
Fixed high speed. . . . . . . . . . . .  
Variable speed. . . . . . . . . . . . . .  
Palmar perspiration test . . . . . . . . .  
Steadiness’test 
Largest holc . . . . . . . . . . . . . . . . . .  
Next to largest hole. . . . . . . . . .  
Medium hole. . . . . . . . . . . . . . . . .  
Next to smallest hole.. 




Distant. . . . . . . . . . . . . . . . . . . .  
. . . . . . . . . . . . .  
. . . . . . . . . . . . .  
Near. . . . . . . . . . . . . . . . . . . . . .  
Distant. . . . . . . . . . . . . . . . . . . .  






























































































Symbols: + indicates that the drug effect was more favorable than the placebo effect; 
* The probability is less than one in a hundred that this result could have occurred by 
- indicates that the placebo effect was more favorable than the drug effect. 
chance. 
In  order to secure a measure of autonomic response, as an index of anxiety, 
the perspiration during the driving test was recorded. 
The technique used is an adaptation of the one used by 0. H. Mowrer. The 
subject’s thumb is swabbed with a solution of ferric chloride (13 gm. of anhy- 
drous ferric chloride in 400 cu. cm. of chemically pure acetone, with 3 drops of 
hydrochloric acid added to stabilize the solution). A small square of paper, 
soaked in a 5 per cent aqueous solution of tannic acid and allowed to dry, is 
placed on the thumb and held firmly by a small foam-rubber pad taped to the 
subject’s thumb. The pressure with which the pad is taped to the thumb is 
roughly controlled by attempting to equalize the amount of compression of the 
pad for every administration. The pad is worn throughout the driving test. 
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As the subject perspires, the ferric chloride dissolves and makes a stain on the 
paper. The darkness of the stain is proportional to the amount of sweating. 
A score is obtained by placing the ferric chloride paper over the half-inch 
aperture in a transmission-type photometer and reading the percentage of light 
transmission of the darkest area. One hundred per cent transmission is set 
at the amount of light transmitted by the nonstained part of the paper, and the 
score is expressed in percentage of this value. 
The temperature and relative humidity of the testing room were also recorded 
during all the testing sessions, so that these variables could be controlled sta- 
tistically in evaluating the measure of perspiration. 
Perspiration was 
significantly greater under meprobamate, as compared with the placebo. Dex- 
troamphetamine sulfate and alcohol did not produce any definite effect. The 
results with meprobamate were exactly contrary to  expectation, so we double 
checked to determine that there had been no error in recording or computing 
the scores. 
Intercorrelations between palmar sweating and room humidity and tempera- 
ture were so low under meprobamate and under placebo that correlated changes 
in these variables could not explain the difference. NIoreover, our data analy- 
sis showed a similar effect in males and females, so the over-all results cannot 
be explained by any differential, such as degree of vasomotor stability, between 
the sexes. Males sweated more than females under all conditions. It is un- 
clear in the literature and to us whether the perspiration test is, as usually sug- 
The results of the perspiration measure were clear-cut. 
FIGUBE 2. Apparatus for the Whipple Steadiness Test. 
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gested, a measure of anxiety, or whether it may be related more to muscular 
exertion or some other function. 
The steadiness test used is an adaptation of the Whipple Steadiness Test 
(FIGURE 2). The test panel contains a series of holes decreasing in size from 
x6 in. to x6 in. The subject is asked to insert a round metal stylus $6 in. 
in diameter into each of the holes and to hold it there for 15 sec. without 
letting it touch the sides of the hole. The apparatus is wired so that a timer 
is activated whenever the stylus touches the sides of the hole during the 15-sec. 
test period. 
Scores were obtained for 3 trials on each of the 5 holes, representing the total 
amount of time that the stylus touched the rim of the hole. The scores were 
weighted to compensate for the varying difficulties of task for each hole, in 
making direct comparisons and to facilitate combination of the scores from the 
different-sized holes. For weighting, the scores for the x6-in. hole were mul- 
tiplied by 10; the x6-in. hole, by 4; the 746-in. hole, by l ;  the 4.is-h. hole, by 
>i; and the 946411. hole, by +i.i~. 
With placebo and alcohol there was a significant impairment of steadiness 
for the medium-size hole, but not with meprobamate or dextroamphetamine 
sulfate. There was a similar impairment (nearly to the level of significance) 
for the other 3 of the 4 largest holes. There was a suggestion that meprobam- 
ate tends to counteract alcohol. 
FIGURE 3. Bausch and Loinb master-model Ortho-rater. 
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For the visual tests we employed the master-model Ortho-rater (FIGURE 3) 
constructed by the Bausch and Lomb Optical Company, Rochester, N. Y .  
This device is designed to present slides for testing various visual functions, 
with distance and illumination controlled. It consists of 2 octagonal slide- 
holding drums set inside a boxlike apparatus. A binocular eyepiece is located 
at  one end of the box. One of the drums is much closer to the eyepiece than the 
other and is used for testing near vision; the farther drum is used for testing 
distant vision. The test slides are fastened to the drum and are easily changed 
by rotating the drum with an external handle. Standard Ortho-rater testing 
procedures were used for 7 visual tests. 
Acuity was determined for both far and near vision; depth perception scores 
were determined for distant vision only. Vertical and lateral phorias for both 
near and far vision were also measured. Phoria scores indicate the relative 
posture or muscular balance of the eyes in relation to each other under condi- 
tions of controlled accommodation. A perfect vertical phoria score indicates 
that the horizontal midline in both the right and left visual fields is in the same 
axis. A perfect lateral phoria score indicates the same for the vertical midline. 
In TABLE 1 the plus scores would indicate exophoria; minus scores would indi- 
cate esophoria. 
The results of the visual tests yielded no significant differences between the 
drugs and the placebo. 
Summary of Meprobamate Ejects 
In the analysis of results, using the critical ratio of correlated measures, we 
compared all possible pairs of treatments on all test scores, as well as tempera- 
ture and humidity readings during the perspiration test-a total of 230 critical 
ratios and correlation coefficients. The same statistical analyses were also done 
separately for the males alone and for the females alone. No clear sex dif- 
ferences in the effects of meprobamate were demonstrated; the results, there- 
fore, are reported for the total group of subjects. 
The intercorrelations between scores on all 23 test variables were also ob- 
tained for the placebo condition and for the meprobamate condition. The 
several measures of accuracy, of reaction time, and of steadiness were highly 
intercorrelated, suggesting that each set of these alternate measures validly 
samples a single domain. 
The correlation coefficients between the scores on any one test on different 
clays, that is, under different drug treatments, ran between 0.45 and 0.90, with 
a median of 0.68. This indicates a satisfactory reliability for the different 
measures. 
In TABLE 1 the column headed “Meprobamate” shows the mean differences 
between the scores obtained under meprobamate and placebo conditions on the 
driving tests, the perspiration test, and the steadiness and visual tests. The 
plus scores represent differences in which the performance is more favorable 
under meprobamate. Deciding what direction of effect is favorable on any 
test naturally involves a value judgment but, in most cases, there could be 
Fixed low speed., . . . . . . . . . . . . .  4-0.08 
Symbols: + indicates that the meprobamate and alcohol effect was more favorable than 
the placebo and alcohol effect; - indicates that the placebo and alcohol effect was more favor- 
able than the meprobamate and alcohol effect. 
Next to largest hole. . . . .  , . . . . . .  +O. 08 
little argument. The only significant difference here is the greater amount of 
perspiration with meprobamate. As we have noted, this result is unexpected, 
and its interpretation is not clear. 
What are the effects of alcohol as contrasted with those of meprobamate and 
alcohol together? In TABLE 1 the columns headed ‘(Meprobamate and alcohol” 
and “Placebo and alcohol” show the effects of these drugs as compared with 
the placebo on all of the tests. The only statistical significance revealed is 
the effect of alcohol on the measure of steadiness. Perhaps the absence of 
other clear-cut effects of alcohol on driving and vision can be attributed to the 
relatively small dosage of less than 1 oz. of alcohol. Comparing the results 
for the combined meprobamate and alcohol offers no evidence that the com- 
bination has any more unfavorable effects than alcohol alone. 
A direct comparison of the performances on the same tests under alcohol 
and under alcohol plus meprobamate yields the findings shown in TABLE 2. 
The plus scores indicate more favorable performance under combined alcohol 
and meprobamate as compared with alcohol alone. None of the differences 
is statistically significant. 
Examination Performance and Anxiety 
Another research study provides more general evidence for the absence of 
deleterious effects of meprobamate on normal functioning. This experiment 
was carried out in collaboration with Wilbert McKeachie of the Department 
of Psychology at the University of Michigan. In  connection with a regular 
mid-term examination in a college psychology course, a class of 276 students, 
Reaction time Depth perception. . . . . . . . .  , . . . .  -0.03 
Variable speed.. . . . . . . . . . . . . . .  -0.12 
Palmar permiration test . . .  +0.12 
Near . .  . .  , . . . . . . . . . . . . . . . . .  0.0 
Distant . . . . . . . . . . . . . .  , . . . . . .  +0.10 
N e a r . .  . , . .  , . . . . . . . . . . . . . . . .  +0.07 
Distant . . . . . . . . . . . . . . . . . . . .  0.0 
Near. . . . . . . . . . . . . . . . . . . . . . .  -0.03 
Vertical phoria 
Lateral phoria.. . . . . . . . . . . . . . .  0.0 
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after being assured it would have no serious effects, agreed to take a pill of 
unstated composition 1 hour before the examination*. Selected a t  random, 138 
of the students received 400 mg. of meprobamate, and 138 received a placebo 
(5 gm. of acetyl salicylic acid). Performance on the examination was not 
impaired for those who received meprobamate; indeed, it was slightly better, as 
might be expected, since it is obvious that anxiety and apprehension interfere 
with efficiency on examinations. Support for this interpretation comes also 
from the answers to 5 questions at  the end of the examination, asking about 
worry and slress during the period. The students who received meprobamate 
reported somewhat less anxiety than the others, but the difference was not 
clearly significant. 
An unexpected finding in these results was that meprobamate had a greater 
effect on females than on males, both in improving examination scores and in 
reducing anxiety. In  the research on driving, we also found that dextroam- 
phetamine sulfate, and perhaps other drugs, produced greater performance 
effects on females than on males. Since body weight was not taken into ac- 
count in the dosage, the interpretation of these findings is not clear. How- 
ever, sex differences in drug action are well known, as, for example, in the 
hypnotic effects of barbiturates. 
Summary 
The primary finding of these studies is that meprobamate alone, even in 
double the usual dosage, produces no behavioral toxicity in our subjects as 
measured by our tests of driving, steadiness, and vision. Meprobamate sig- 
nificantly increases sweating, an unexpected and unexplained finding. 
Our study also indicates that, while alcohol definitely impairs performance 
on some tests, combining meprobamate with the alcohol does not significantly 
add to this unfavorable effect on any test. Our data give no grounds for pre- 
venting persons under the usual dosages of meprobamate from driving automo- 
biles, or even from driving under meprobamate after drinking alcohol in 
amounts that would not ordinarily affect driving ability. 
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Discussion of the Paper 
QUESTION: I should like to put a faint note of caution on the all-sweeping 
summary that the doses of meprobamate do not interfere with judgment or 
mechanical skill, or that doses of meprobamate plus alcohol are not in any 
* We recognize, of course, that such assurances could have a suggestion effect on the out- 
come. but they were obviously necessary in order to obtain co-operation of the subjects. 
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way synergistic. I feel that the enthusiasm for the experiment, while it is 
excellent for the first series of tests, certainly does not take into consideration 
what Berger has already emphasized, namely, that with meprobamate there is 
a considerable latent period before action takes place. Many people who take 
meprobamate do so, not once a day, but three, four, or more times a day for 
several days. At  the end of such a period of dosage the residual effects from 
many partially destroyed doses of meprobamate could be considerably greater 
than even the one double dose. I cannot question the results as presented, 
but I do advise caution in their application. 
D. G. MARQUIS: Certainly we have no desire to generalize beyond the rea- 
sonable limits represented by the particular test data. The latent period of 
meprobamate is no more than 30 min., and we used a 30-min. waiting period. 
The tests extended over an hour following this waiting period. Since the usual 
dosage is 1 pill every 4 hours, we were given no reason to believe that there 
would be a cumulative effect any greater than the effect of 2 pills taken simul- 
taneously. 
QUESTION: 1 wonder if Marquis has any comments to make regarding the 
distribution within the group that averaged out as nonspecific. Were there 
any patterns that suggested that some people behaved differently than others 
under these conditions? 
D. G. MARQUIS: Certainly there were individual differences, but there is no 
way to evaluate their significance except by a system of subgrouping of the 
individuals. While we did find differences in magnitudes, such as the fact that 
women do not sweat as much as men, the drug effects were always in the same 
direction. 
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